CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 90 filers reported holding CYTEK BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,587,910 | -64.2% | 6,809,404 | -44.6% | 0.74% | -62.7% |
Q2 2023 | $105,022,537 | -14.6% | 12,297,721 | -8.1% | 1.98% | -28.8% |
Q1 2023 | $122,971,886 | -10.0% | 13,381,054 | 0.0% | 2.78% | +0.5% |
Q4 2022 | $136,620,561 | -30.6% | 13,381,054 | 0.0% | 2.77% | -34.1% |
Q3 2022 | $196,969,000 | +37.2% | 13,381,054 | 0.0% | 4.20% | +9.8% |
Q2 2022 | $143,578,000 | -0.5% | 13,381,054 | 0.0% | 3.83% | +21.6% |
Q1 2022 | $144,248,000 | -8.0% | 13,381,054 | +39.3% | 3.15% | +13.9% |
Q4 2021 | $156,787,000 | -23.8% | 9,607,028 | 0.0% | 2.76% | -3.0% |
Q3 2021 | $205,686,000 | – | 9,607,028 | – | 2.85% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
Miura Global Management | 820,000 | $12,070,000 | 7.24% |
RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
Parkwood LLC | 42,336 | $623,000 | 0.09% |
PDT Partners, LLC | 31,436 | $463,000 | 0.07% |